Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Time of onset and factors associated with delayed response post intradetrusor injection of onabotulinumtoxin a in patients with neurogenic and idiopathic overactive bladder syndrome. | Urol Ann | 2023 | 37304520 | PubTator, text mining | PubMed |
| Awakening of Dormant Breast Cancer Cells in the Bone Marrow. | Cancers (Basel) | 2023 | 37296983 | PubTator, text mining | PubMed |
| A comprehensive look at the psychoneuroimmunoendocrinology of spinal cord injury and its progression: mechanisms and clinical opportunities. | Mil Med Res | 2023 | 37291666 | PubTator, text mining | PubMed |
| A comprehensive mechanistic model of adipocyte signaling with layers of confidence. | NPJ Syst Biol Appl | 2023 | 37286693 | PubTator, text mining | PubMed |
| Vertical sleeve gastrectomy-derived gut metabolite licoricidin activates beige fat thermogenesis to combat obesity. | Theranostics | 2023 | 37284437 | PubTator, text mining | PubMed |
| Progress and obstacles in transplantation of brown adipose tissue or engineered cells with thermogenic potential for metabolic benefits. | Front Endocrinol (Lausanne) | 2023 | 37265692 | PubTator, text mining | PubMed |
| Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume. | Res Rep Urol | 2023 | 37251707 | PubTator, text mining | PubMed |
| Investigation of fatty acid metabolism-related genes in breast cancer: Implications for Immunotherapy and clinical significance. | Transl Oncol | 2023 | 37247503 | PubTator, text mining | PubMed |
| Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity. | Int J Mol Sci | 2023 | 37239935 | PubTator, text mining | PubMed |
| PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. | Antioxidants (Basel) | 2023 | 37237941 | PubTator, text mining | PubMed |
| Inhibition of prejunctional parasympathetic pathways by β3-adrenoceptor agonists in the isolated pig detrusor: comparison with human detrusor studies. | Front Pharmacol | 2023 | 37234719 | PubTator, text mining | PubMed |
| Brown adipose tissue and aging: A potential role for exercise. | Exp Gerontol | 2023 | 37224933 | PubTator, text mining | PubMed |
| Inequities in Filled Overactive Bladder Medication Prescriptions in the US. | JAMA Netw Open | 2023 | 37223899 | PubTator, text mining | PubMed |
| Effect of High-Intensity Interval Training on Fatty Infiltration After Delayed Rotator Cuff Repair in a Mouse Model. | Orthop J Sports Med | 2023 | 37223073 | PubTator, text mining | PubMed |
| [From genotype to phenotype: amylase gene in childhood obesity]. | Rev Med Inst Mex Seguro Soc | 2023 | 37216679 | PubTator, text mining | PubMed |
| Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. | Front Oncol | 2023 | 37205195 | PubTator, text mining | PubMed |
| Efficacy and safety of mirabegron in the treatment of overactive bladder syndrome after radical prostatectomy: a prospective randomized controlled study. | Front Oncol | 2023 | 37205190 | PubTator, text mining | PubMed |
| Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review. | Transl Oncol | 2023 | 37201250 | PubTator, text mining | PubMed |
| Subcutaneous Adipose Tissue Transcriptome Highlights Specific Expression Profiles in Severe Pediatric Obesity: A Pilot Study. | Cells | 2023 | 37190014 | PubTator, text mining | PubMed |
| Social determinants of health, health disparities, and adiposity. | Prog Cardiovasc Dis | 2023 | 37178992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=17